Permacol collagen paste
DeviceCollagen paste intended to reinforce soft tissue where filling is required such as to repair fistulas, including anal and rectal fistulas.
NCT Number: NCT01624350
This will be a prospective, multi-center, post-market, single arm observational study to collect clinical outcome data on the use of Permacol™ Collagen Paste in the treatment of anorectal fistulas.
The subjects will have baseline and day of surgery visits performed, and then subjects will return to the investigator for evaluation of defect and safety related morbidities at follow up visits scheduled at 1 month, 3 months, 6 months and 12 months post-surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Aalborg Hospital, Aalborg, Denmark
The study will enroll 100 subjects at up to 10 centers throughout the European Union. The expected duration of the enrollment period is approximately 9 months. The duration of each subject's participation in the study will be approximately one year. However, at sites where the routine follow-up period is greater than one year, subjects may be followed for up to 36 months at their surgeon's discretion if they agree to it.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Key Inclusion Criteria:
Key Exclusion Criteria:
Collagen paste intended to reinforce soft tissue where filling is required such as to repair fistulas, including anal and rectal fistulas.
Time frame: 6 months
Clinical assessment of fistula healing as defined by 1) no discharge from the fistula and 2) the external opening has closed.
Time frame: 3 months and 12 months
Clinical assessment of fistula healing as defined by 1) no discharge from the fistula and 2) the external opening has closed.
Time frame: Baseline, and 3 months, 6 months and 12 months post op
Quality of Life by EQ-5D questionnaire is a standardized measure of health status. It is a 25-item questionnaire that measures quality of life of patients pre and post surgery in the following categories: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each category has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems.
Time frame: 3 months, 6 months and 12 months
Fecal Incontinence change from baseline as measured by CCF-FI questionnaire. This questionnaire is a summed score of 5 individual parameters (frequency of incontinence to gas, liquid solid, of need to wear pad, and of lifestyle changes) It is measured from a patient-completed questionnaire with each parameter given a score from 0 to 4, with 0 indicating its absence and 4 indicating daily presence. These values are added to give a total score ranging from 0 to 20 (0 indicating perfect control, 10-15 indicating moderate incontinence, and greater than 15 indicating severe incontinence.
Time frame: Between the first and last visits
Patient satisfaction questionnaire included questions regarding fecal continence and overall satisfaction with the operation.
Time frame: Baseline, 1 month, 3 months, 6 months and 12 months
Pain by VAS (Visual Analog Scale) VAS is a 10-point scale with 0 being no pain and 10 being the most pain.
Medtronic - MITG
Industry
MASERATI 100 - A Prospective, Multi-center, Post-mArket, Single-arm obsERvATIonal Study to Collect Clinical Outcome Data on the Use of Permacol™ Collagen Paste in the Treatment of Anorectal Fistulas
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07579715
Anal Fistula, Digestive System Diseases
Islamabad, Pakistan
View Trial DetailsNCT07603635
Anal Fistula Surgery, Digestive System Diseases
Kayseri, Turkey (Türkiye)
View Trial DetailsNCT07562672
Digestive System Diseases, Digestive System Fistula
Zhengzhou, Henan, China
View Trial DetailsNCT06663527
Digestive System Diseases, Digestive System Fistula
Hefei, Anhui, China
View Trial Details